Rad51 Polymorphism and Breast Cancer Risk
Author Information
Author(s): Ricks-Santi Luisel J, Sucheston Lara E, Yang Yang, Freudenheim Jo L, Isaacs Claudine J, Schwartz Marc D, Dumitrescu Ramona G, Marian Catalin, Nie Jing, Vito Dominica, Edge Stephen B, Shields Peter G
Primary Institution: Howard University Cancer Center
Hypothesis
The study investigates the relationship between Rad51 polymorphism and DNA repair capacity in BRCA1 mutation carriers and sporadic breast cancer risk.
Conclusion
Mutagen sensitivity may serve as a useful biomarker for identifying higher-risk individuals among women with BRCA1 mutations.
Supporting Evidence
- Breast cancer diagnosis was significantly associated with the mutagen sensitivity assay among women from BRCA1 families.
- The Rad51 5'UTR 135 C>G genotype was associated with higher mean number of breaks per cell.
- Associations were found between BRCA1 SNPs and mutagen sensitivity in family-based analyses.
- Rad51 polymorphism was not associated with breast cancer risk in the population-based study.
Takeaway
This study looked at how well people's DNA can repair itself and how that might affect their chances of getting breast cancer, especially for those with certain gene mutations.
Methodology
The study used a mutagen sensitivity assay to measure DNA repair capacity in lymphoblasts from women with known BRCA1 mutations and conducted a case-control study for sporadic breast cancer.
Potential Biases
Potential selection bias due to exclusion of BRCA1/2 mutation carriers who underwent prophylactic surgeries.
Limitations
The small sample size may limit the statistical power to detect genotype-phenotype relationships.
Participant Demographics
Participants included women with known BRCA1 mutations, some with a history of breast cancer and others without.
Statistical Information
P-Value
0.004
Confidence Interval
95% CI: 1.5-6.7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website